← SynDRA
DUP-697
SynDRA canonical compound SYN0002223 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- MT-CO1
- MT-CO2
- PTGS1
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- HDAC6
- HPGD
- HSD17B10
- KDM4E
- TDP1
- TSHR
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2C9
- CP2CJ
- PAFA
- RAPGEF4
- RPGF4
Drug classes
- Anti-Inflammatory Agents, Non-Steroidal
- Cyclooxygenase Inhibitors
Cross-references
Synonyms
- MRWLZPOFPA
- UNII-MRWLZPOFPA
- CHEMBL42485
- CHEBI:4720
- 5-Bromo-2-(4-fluorophenyl)-3-(4-methysulfonylphenyl)thiophene
- 5-bromo-2-(4-fluorophenyl)-3-(4-methylsulfonylphenyl)thiophene
- CPD000466299
- Thiophene, 5-bromo-2-(4-fluorophenyl)-3-(4-(methylsulfonyl)phenyl)-
- Thiophene, 5-bromo-2-(4-fluorophenyl)-3-[4-(methylsulfonyl)phenyl]- [CAS]
- 5-bromo-2-(4-fluorophenyl)-3-[4-(methylsulfonyl)phenyl]thiophene
- 5-Bromo-2-(4-fluorophenyl)-3-(4-(methylsulfonyl)phenyl)thiophene
- SMR000466299
- RefChem:913274
- DTXCID80159348
- SR-01000597563
- C17H12BRFO2S2
- AJFTZWGGHJXZOB-UHFFFAOYSA-N
- Tocris-1430
- MLS000758941
- MLS001424298
- orb1707352
- SCHEMBL1041241
- GLXC-07889
- HMS2052D13
- HMS2232L09
- HMS3267J18
- HMS3394D13
- HMS3412B03
- HMS3649A06
- HMS3676B03
- EX-A7577
- BDBM50029600
- MFCD02684527
- AKOS024456593
- CCG-101192
- NC00442
- NCGC00025161-01
- MS-27097
Look up DUP-697 in the interactive SynDRA portal →